Found: 2 articles
Article | Edition |
---|---|
Sukhomlinova I.M., Bakulin I.G., Kabanov M.Yu.
Tocilizumab, baricitinib, olokizumab and dexamethasone: comparative characteristics and prognosis of efficacy in COVID-19
|
№7 / 2022 |
Gomon Yu.M., Kolbin A.S., Strizheletsky V.V., Ivanov I.G., Sultanova F.M., Balykina Yu.E., Verbitskaya E.V.
A systematic review with meta-analysis of the safety of Janus kinase inhibitors in relation to the risks of secondary bacterial infections
|
№4 / 2022 |